4th IMPAKT Breast Cancer Conference
IMPAKT - IMProving cAre and Knowledge through Translational research
Date: 03. - 05.05.2012
Today, it is imperative for basic researchers to understand and address clinical challenges and for physicians to possess the knowledge and skills to integrate and use new technologies
IMPAKT is a unique Breast Cancer Conference that meets these needs by bridging the gap between research and clinic while also providing the right environment for young professionals to network with and access the knowledge of their senior counterparts
IMPAKT focuses on translational research in breast cancer and on innovative ways of developing new agents
It is a valuable meeting which brings together pre-clinical and clinical researchers from Academia and Industry, junior and senior oncologists and facilitates the role of mentor and the importance of sharing knowledge to improve careers
The rapid translation of biologically-based laboratory discoveries into daily clinical practice is also important, but equally important is the trip back from the clinic to the laboratory, to further explore and explain clinically observed tumor biology and behavior
IMPAKT was launched in 2009 by the Breast International Group and the European Society for Medical Oncology, in collaboration with a multidisciplinary alliance of European breast cancer organizations and patient groups and is an annual conference
IMPAKT is unique: It provides information on the myriad discoveries that already have or will have impact on breast cancer research and treatment in the near future
It puts into perspective advances on a molecular level in cell biology, molecular pathways exploited for clinical purposes, and a wide range of diagnostic, prognostic and predictive tools for breast cancer
It is the place where discussion about what biomarkers are, how they should be used in clinical trials and decisions about biomarkers are taken
It includes a consensus session for selected biomarkers with the aim of producing and publishing a set of IMPAKT biomarker guidelines
It keeps in tune with scientific progress in breast cancer research as the therapeutic road from the laboratory to the clinic shortens
It has educational sessions for existing diagnostics and new systems providing an understanding of how diagnostics should be added to translational research
It focuses on premier data and technologies that sharpen the knife of molecular dissection and define the cellular structures that determine responsiveness to novel therapies
It includes sessions on ongoing clinical trials
It promotes collaboration in breast cancer research, new ideas for projects and foster new contacts
Medical topics:
Gynaecology and Obstetrics, Gynaecological Oncology, Internal Medicine, Internal Medicine and Haematology and Oncology
Host
European Society for Medical Oncology (ESMO)
Go to address
Venue:
SQUARE Brussels Meeting Centre
rue Mont des Arts
Glass Entrance
BE 1000 Brüssel
Go to map
Host:
European Society for Medical Oncology (ESMO)
Via L. Taddei 4
CH 6962 Viganello-Lugano
Phone: +41-91-973-19-00
Fax: +41-91-973-19-02
E-mail: esmo@esmo.org
Website: http://www.esmo.org
Organiser:
European Society for Medical Oncology (ESMO)
Via L. Taddei 4
CH 6962 Viganello-Lugano
Phone: +41-91-973-19-00
Fax: +41-91-973-19-02
E-mail: esmo@esmo.org
Website: http://www.esmo.org
Registration:
Online registration: http://www.esmo.org/events/breast-2012-impakt/registration.html
E-mail: registration@esmo.org
Venue:
SQUARE Brussels Meeting Centre
rue Mont des Arts
Glass Entrance
BE 1000 Brüssel
Rating
Further Information
Frequency: annually
CME points: 1
Expected number of participants: 800
